Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS other · 2016-09-13Clinical Trial Update: forREAL: FORXIGA PRESCRIPTION EVENT MONITORING PROGRAM (PEMP)
The FORXIGA prescription event monitoring program (PEMP) for dapagliflozin in type 2 diabetes has been terminated. This serves as a status u…
-
CLINICAL_TRIALS trial_result · 2016-09-09Clinical Trial Update: European, Open-label, Prospective, Multinational, Multicenter Study in Adult Subjects With Type 1 or Type 2 Diabetes Previously on MDI or CSII Therapy. Subjects Home Setting is Considered Routine Practice. [NA]
A completed European open-label, prospective, multicenter study in adults with type 1 or type 2 diabetes previously treated with MDI or CSII…
-
CLINICAL_TRIALS trial_result · 2016-09-09Clinical Trial Update: Validation of an RLIP76 Assay in Humans [NA]
The document reports a completed clinical trial validating a RLIP76 biomarker assay in humans. It concerns Type 2 Diabetes.
-
CLINICAL_TRIALS research · 2016-09-09Clinical Trial Update: Aspirin and Renal Disease Progression in Patients With Type 2 Diabetes [Phase 3]
A Phase 3 clinical trial update examining aspirin's effect on renal disease progression in patients with type 2 diabetes. No results or stat…
-
CLINICAL_TRIALS trial_result · 2016-09-07Clinical Trial Update: An Investigational Drug Co-Administered With Insulin in Patients With Type 2 Diabetes (0478-065) [Phase 3]
A Phase 3 trial investigating an investigational drug co-administered with insulin in Type 2 diabetes has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-09-05Clinical Trial Update: Study of Stress Hyperglycemia as an Indicator of Diabetes Mellitus
A Yale-sponsored clinical trial evaluating whether stress hyperglycemia can serve as an indicator for type 2 diabetes has been terminated.
-
CLINICAL_TRIALS research · 2016-09-05Clinical Trial Update: Study on Improvement of Blood Glucose Control in Patients With Diabetes Type 2 Using SMBG [NA]
This clinical trial update reports termination of a Roche-sponsored study evaluating self-monitoring of blood glucose to improve glycemic co…
-
CLINICAL_TRIALS trial_result · 2016-09-05Clinical Trial Update: Effect of Renin-angiotensin System Blockers on Glomerular Filtration Rate in Patients With Hypertension, Type 2 Diabetes With Normoalbuminuria [Phase 4]
Phase 4 clinical trial update evaluating the effect of renin-angiotensin system blockers on glomerular filtration rate in adults with hypert…
-
CLINICAL_TRIALS trial_result · 2016-09-05Clinical Trial Update: The Aboriginal Youth Mentorship Program [NA]
A status update confirms the Aboriginal Youth Mentorship Program clinical trial has completed, involving Type 2 diabetes mellitus and obesit…
-
CLINICAL_TRIALS trial_result · 2016-09-02Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin [Phase 4]
Phase 4 study assessing whether adding canagliflozin to metformin and sitagliptin improves glycemic control in type 2 diabetes. Results were…
-
CLINICAL_TRIALS research · 2016-09-02Clinical Trial Update: Exenatide Plus Pioglitazone Versus Insulin in Poorly Controlled T2DM [NA]
This clinical trial update compares exenatide plus pioglitazone versus insulin in patients with poorly controlled type 2 diabetes; current s…
-
CLINICAL_TRIALS trial_result · 2016-09-01Clinical Trial Update: Liraglutide and Heart Failure in Type 2 Diabetes [Phase 2]
This is a Phase 2 trial update for liraglutide in people with type 2 diabetes and heart failure. The study status is completed, but the snip…
-
CLINICAL_TRIALS trial_result · 2016-09-01Clinical Trial Update: Study Of AVANDAMET® With Or Without Insulin In Type II Diabetes Mellitus Patients. AVANDAMET® is a Registered Trademark of the GSK Group of Companies. [Phase 3]
A completed Phase 3 clinical trial evaluating AVANDAMET with or without insulin in patients with Type 2 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2016-09-01Clinical Trial Update: Effect Of Rosiglitazone On Carotid Intima Media Thickness In Patients With Insulin Resistance Syndrome And/Or Type 2 Diabetes [Phase 4]
This Phase 4 trial update evaluates the effect of rosiglitazone on carotid intima-media thickness in patients with insulin resistance syndro…
-
CLINICAL_TRIALS trial_result · 2016-08-31Clinical Trial Update: TAK-648 Multiple-Rising Dose Study in Healthy Japanese Participants and Non-Japanese Participants With Type 2 Diabetes Mellitus [Phase 1]
TAK-648 was evaluated in a Phase 1 multiple-rising-dose study in healthy Japanese and non-Japanese participants with Type 2 Diabetes Mellitu…
-
CLINICAL_TRIALS trial_result · 2016-08-31Clinical Trial Update: A Novel Positron Emission Tomography (PET) Approach to Measuring Myocardial Metabolism [NA]
A completed clinical trial tested a novel PET imaging approach to measure myocardial metabolism in adults with Type 2 Diabetes Mellitus; res…
-
CLINICAL_TRIALS trial_result · 2016-08-30Clinical Trial Update: Gene Polymorphism Associated With Macroangiopathy in Type 2 Diabetes Patients
A completed clinical trial investigates whether a specific gene polymorphism is associated with diabetic macroangiopathy in type 2 diabetes …
-
CLINICAL_TRIALS trial_result · 2016-08-29Clinical Trial Update: Pharmacokinetic Study of CYCLOSET ® 0.8 mg Tablets in Children and Adolescent Type 2 Diabetes Mellitus Subjects [Phase 1]
A Phase 1 pharmacokinetic study evaluating Cycloset (bromocriptine) 0.8 mg tablets in children and adolescents with Type 2 diabetes mellitus…
-
CLINICAL_TRIALS research · 2016-08-29Clinical Trial Update: Qingdao Diabetes Prevention Project [NA]
A completed clinical trial update on the Qingdao Diabetes Prevention Project, a study led by the University of Helsinki focusing on Type 2 d…
-
CLINICAL_TRIALS trial_result · 2016-08-26Clinical Trial Update: Glycemic Index in Subjects With Diabetes Mellitus Insulin Requesting [NA]
A completed clinical trial evaluating glycemic index in subjects with type 2 diabetes mellitus who are requesting insulin.
-
CLINICAL_TRIALS research · 2016-08-25Clinical Trial Update: Effect of Nutritional Counseling Based on Diet Quality on Metabolic Control in Patients With Type 2 Diabetes Mellitus [NA]
This clinical trial update describes a study evaluating whether nutritional counseling based on diet quality can improve metabolic control i…
-
CLINICAL_TRIALS trial_result · 2016-08-24Clinical Trial Update: Study of Ro 205-2349 in Patients With Type 2 Diabetes Mellitus [Phase 2]
A Phase 2 clinical trial evaluating Ro 205-2349 for Type 2 diabetes mellitus has completed.
-
CLINICAL_TRIALS research · 2016-08-24Clinical Trial Update: Meta-analyses of Impotrant Food Sources of Sugars and Incident Cardiometabolic Diseases
An update describing meta-analyses on how different dietary sugar sources relate to the development of cardiometabolic diseases. The analyse…
-
CLINICAL_TRIALS research · 2016-08-24Clinical Trial Update: Meta Analysis of the Effect of a Low Glycemic Index Diet and Glycemic Load on Body Weight
This document reports a meta-analysis assessing whether a low glycemic index diet and low glycemic load influence body weight. The findings …
-
CLINICAL_TRIALS trial_result · 2016-08-24Clinical Trial Update: A Study of the Pharmacokinetics/Pharmacodynamics of GK Activator (2) in Type 2 Diabetes Patients With Hepatic Impairment. [Phase 1]
The Phase 1 PK/PD study of GK Activator (2) in patients with Type 2 diabetes and hepatic impairment has been terminated.